There are 2137 resources available
1532P - Nab-paclitaxel plus S1 with or without sintilimab in metastatic pancreatic ductal adenocarcinoma: A single-center, retrospective study
Presenter: Qu Liu
Session: E-Poster Display
Resources:
Abstract
1534P - Multivariable analysis of real-world clinical outcomes associated with dose reductions (DRs) for patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC) treated with liposomal irinotecan
Presenter: Laith Abushahin
Session: E-Poster Display
Resources:
Abstract
1535P - Paclitaxel based intraperitoneal chemotherapy for gastric and pancreatic cancer with peritoneal metastases achieves higher conversion surgery rate and longer survival
Presenter: Koya Sawai
Session: E-Poster Display
Resources:
Abstract
1536P - Chemotherapy vs best supportive care in octogenarian and older stage IV pancreatic cancer patients
Presenter: Antonino Carmelo Tralongo
Session: E-Poster Display
Resources:
Abstract
1537P - Phase I/II study with CXCL12 inhibitor NOX-A12 and pembrolizumab in patients with microsatellite-stable, metastatic colorectal or pancreatic cancer
Presenter: Niels Halama
Session: E-Poster Display
Resources:
Abstract
1538P - Deleterious germline mutations in patients with pancreatic ductal adenocarcinoma
Presenter: Zhiming Zhao
Session: E-Poster Display
Resources:
Abstract
1539P - Signature protein biomarkers in serum for diagnosis of pancreatic ductal adenocarcinoma
Presenter: Sidsel Christy Lindgaard
Session: E-Poster Display
Resources:
Abstract
1540P - Comprehensive molecular profiling of pancreatic ductal adenocarcinoma in Chinese population
Presenter: Rong Liu
Session: E-Poster Display
Resources:
Abstract
1541P - The genomic features of Chinese pancreatic adenocarcinoma and the implications for therapy
Presenter: Weilin Wang
Session: E-Poster Display
Resources:
Abstract
1542P - Untargeted metabolomics to identify novel biomarkers of pancreatic cancer
Presenter: Octavio Caba
Session: E-Poster Display
Resources:
Abstract